PREventsSM Program
The PREvents Program is an exclusive program for clinicians to enhance and accelerate their clinical education regarding advancements in the identification, management, and treatment of cardiovascular disease (CVD). CVD remains the number one cause of death in the world. 50% of CVD events strike in patients with normal lipid levels1. 75% of heart attacks and most strokes are caused by plaque rupture and thrombosis2. The PLAC® Test is the only blood test that helps identify hidden risk for heart attack and stroke. Early detection and more aggressive treatment can help prevent CVD events.
The PREvents Program Goals:
- Apply proven practices to help improve the health of your patients through more accurate risk classification.
- The Program will enable you to learn from leading experts in the field of vascular inflammation, risk assessment, and treatment to begin incorporating advanced CVD tests into your standard of care.
- You will gain insights from clinical case studies and learn how your peers move through the decision processes to ultimately improve early identification and management of your CVD patients.
Discover Hidden Risk - The PLAC Test Fills An Important Clinical Need.
1. Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009;157:111-7.e23.
2. Kolodgie F, et al. Lipoprotein-Associated Phospholipase A2 Protein Expression in the Natural Progression of Human Coronary Atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:2523-2529.